Bond Traders in Japan Can’t Stop Fretting Over Long-End Supply
(Bloomberg) -- Moves in Japanese government bonds are signaling concern among traders about the market's ability to absorb an increase in supply of longer-dated notes from July.
Yields on the so-called super-long maturities have risen faster even after the government concentrated the bulk of the rise in its record fiscal 2020 debt sales in shorter maturities. That's sent Japan's curve to its steepest since November, with the spread between the 30-year yield and the 10-year yield climbing back above 50 basis points. It was at 25 basis points around mid-March.
At the heart of the issue is the relative lack of bond-buying support from the Bank of Japan in the super-long sector. While the central bank has ramped up its purchases of short- and medium-tenor securities to help mitigate the impact of the supply deluge, its purchases of bonds maturing over 10 years are largely unchanged so far in 2020.
And given the BOJ's commitment to prevent an excessive flattening of the nation's yield curve, market watchers aren't expecting the scenario to change.
“The yield curve is going to be on a steepening bias as the market faces more issuance,” said Akio Kato, general manager of strategic research and investment at Mitsubishi UFJ Kokusai Asset Management Co. The spread between the 10- and 30-year bonds could extend toward 60 basis points as such wariness prevails, he said.
READ: Japan's Bond Issuance to Surge to 212 Trillion Yen on Stimulus
BOJ officials including Governor Haruhiko Kuroda have repeatedly expressed concerns about how lower super-long bond yields tend to hurt profitability at life insurers, banks and pension funds, and negatively impact consumer sentiment.
“The BOJ has made it clear and the market understands that the central bank wants to steepen the yield curve,” Kato said. “Any signal of increasing purchases in super-long maturities could be taken as a major policy shift and hence the BOJ would want be very careful about that.”
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.